Alembic Limited Share Price NSE India S.E.
Equities
ALEMBICLTD
INE426A01027
Real Estate Development & Operations
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
94.35 INR | -0.42% | +1.78% | +4.25% |
02/04 | Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment | MT |
01/04 | Alembic Limited Announces Cessation of C. P. Buch as an Independent Director | CI |
Sales 2022 | 782M 9.38M | Sales 2023 | 1.27B 15.26M | Capitalization | 15.22B 183M |
---|---|---|---|---|---|
Net income 2022 | 2.22B 26.64M | Net income 2023 | 1.91B 22.86M | EV / Sales 2022 | 23.4 x |
Net cash position 2022 | 270M 3.24M | Net cash position 2023 | 464M 5.56M | EV / Sales 2023 | 11.6 x |
P/E ratio 2022 |
8.37
x | P/E ratio 2023 |
7.99
x | Employees | 271 |
Yield 2022 |
2.49% | Yield 2023 |
3.71% | Free-Float | 27.91% |
1 day | -0.42% | ||
1 week | +1.78% | ||
Current month | +13.06% | ||
1 month | +17.42% | ||
3 months | +1.23% | ||
6 months | +17.57% | ||
Current year | +4.25% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 69 | 02/88/02 | |
Rasesh J. Shah
DFI | Director of Finance/CFO | - | 13/14/13 |
Chairman | 76 | 20/67/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 76 | 20/67/20 | |
Chief Executive Officer | 69 | 02/88/02 | |
Director/Board Member | 44 | 24/13/24 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 94.35 | -0.42% | 579,768 |
25/24/25 | 94.75 | -1.04% | 460,484 |
24/24/24 | 95.75 | +2.08% | 600,677 |
23/24/23 | 93.8 | +1.96% | 618,293 |
22/24/22 | 92 | -0.76% | 722,825 |
Delayed Quote NSE India S.E., April 26, 2024 at 05:13 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
+36.16% | 27.94B | |
-13.74% | 26.97B | |
+25.00% | 26.95B | |
-0.71% | 25.32B | |
+44.49% | 22.58B | |
+2.78% | 19.59B | |
+1.45% | 19.52B | |
+28.54% | 16.23B | |
-14.80% | 14.98B |
- Stock Market
- Equities
- ALEMBICLTD Stock
- ALEMBICLTD Stock